Clinical Trials
4 trialsNCT04446416 2026-04-09
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
NCT02798406 2021-07-15
CAPTIVE
DNAtrix, Inc.
Phase 2 Completed
NCT03626896 2019-06-21
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
NaviFUS Corporation
Phase NA Completed
NCT02197169 2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1 Completed